SB 1449 would require health insurance plans to cover non-opioid alternatives for pain management, such as physical therapy or certain medications. This bill directly affects insurance companies, which would need to provide this coverage, and patients seeking pain treatment without opioids. The key provision mandates that insurers treat these non-opioid options with the same coverage terms as opioid medications. The bill aims to expand access to safer pain management options through insurance coverage.
HB 1966 requires health insurance plans in Missouri to cover nonopioid medications for acute pain (pain expected to last 30 days or less) on the same terms as opioids. It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher out-of-pocket costs for nonopioid options. The law directly affects patients (enrollees) and health insurance plans, ensuring equal treatment for nonopioid alternatives when prescribed by licensed providers. It takes effect for all new or renewed health benefit plans on or after January 1, 2027.
Based solely on the provided abstract and actions, a detailed summary cannot be generated. The abstract only states the bill's title ("Creates a health advocate program in the Department of Health and Senior Services") without describing its specific mechanisms, who it affects, or any concrete provisions. No further details about the program's structure, eligibility, or operational requirements are included in the available context. As the bill is only in its earliest stages (prefiled, first read), no substantive policy changes or affected parties are defined in the provided information.
SB 1200 removes an expiration date from existing provisions related to gender transition care, ensuring these rules remain in effect indefinitely. It directly affects healthcare providers and patients receiving gender-affirming medical services under current state regulations. The bill does not create new policies but extends the duration of existing provisions that would otherwise have ended. This is a procedural change to maintain continuity in current healthcare access.
HB 1941 requires health insurance plans in Missouri to count payments for non-generic medications toward a patient's annual out-of-pocket maximum. Specifically, health carriers must include costs paid by enrollees for medications where a generic version is unavailable when calculating this limit. The bill also prohibits plans from adjusting cost-sharing requirements based on the availability of cost-assistance programs for such medications. This directly affects patients using non-generic prescription drugs who would otherwise face unexpectedly high out-of-pocket expenses. The law applies to most health benefit plans starting August 28, 2026.
SB 1113 requires health insurance plans to cover genetic screenings for hereditary cancer risk without cost-sharing (like copays or deductibles). It directly affects individuals with a family history of certain cancers who would otherwise face high out-of-pocket costs for these screenings. The key provision mandates that insurers include these screenings as a standard benefit in health plans, similar to other preventive services. This policy change ensures broader access to early detection tools for at-risk patients.
SB 1151, the "End Hospital Institutionalization Act," prevents hospitals from keeping medically stable patients unnecessarily in emergency rooms or inpatient settings ("boarding") when community care options are unavailable. It requires juvenile courts to act immediately for children under their jurisdiction or not under court care, and directs the Department of Mental Health to provide case management and treatment (including residential care) for adults with developmental disabilities, serious mental illness, or substance use disorders. Hospitals must notify the relevant authorities when boarding occurs, and the state will reimburse hospitals for boarding costs after notification. This law aims to move patients from hospitals to appropriate community-based care settings without delay.
HB 2109 proposes creating "family justice centers" that bring together multiple service providers - like law enforcement, medical staff, victim advocates, and social workers - into one location to support victims of domestic violence, sexual assault, child abuse, elder abuse, and human trafficking. These centers must maintain strict confidentiality for all victim information, cannot require victims to cooperate with law enforcement to access services, and protect staff from liability when acting in good faith. The bill also adds criminal penalties (up to a class D felony) for tampering with victims or witnesses, including threats, deception, or offering benefits to prevent reporting or prosecution. It affects victims of specified crimes and the organizations providing their services.
HB 1643 legalizes limited personal use of psilocybin (a compound found in "magic mushrooms") for therapeutic purposes under strict conditions. It directly affects adults aged 21+ with qualifying conditions like end-of-life care, PTSD, major depression, or substance use disorders, as documented by a physician. Key provisions require users to obtain medical documentation, use a trained facilitator (with specific qualifications), undergo lab testing, and limit intake to 150mg annually. The bill also shields facilitators, healthcare providers, and labs from legal penalties for compliant use, while maintaining patient confidentiality.
HB 2127 requires healthcare providers to perform a p53 test on all abnormal uterine tissue samples (endometrial samples) collected for diagnosis. This test, which detects protein abnormalities linked to cancer severity, must be done alongside any other existing diagnostic tests. The bill directly affects patients diagnosed with abnormal uterine tissue and their healthcare providers, mandating this specific test to improve diagnosis and treatment planning for uterine cancer. It does not change existing testing requirements but adds the p53 test as a standard step for these cases.
